Viral Vectors

Results Encouraging in Brain Cancer Gene Therapy Trials

Published in Gene Therapy Weekly, March 27th, 1995

Researchers at the U.S. National Institutes of Health (NIH) have seen objective responses in some of the 15 patients treated to date in the first clinical trial of gene therapy in brain tumors, Michael Blaese, M.D., said at the scientific subcommittee session on gene therapy at the American Society of Hematology (ASH) meeting, held in December 1994.

Blaese's remarks were published in the February 1995 issue of Oncology News International.

Although the results are encouraging, "we're not curing anyone with this strategy at the moment," cautioned Blaese, chief of the Clinical Gene Therapy Branch, National Center for Human Genome Research (NCHGR). "But...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-03-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry